Sveriges mest populära poddar
JAMA Clinical Reviews
Hälsa och motionMedicin

Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin

17 min•24 mars 2020

Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.

Fler avsnitt av JAMA Clinical Reviews

Visa alla avsnitt av JAMA Clinical Reviews
Evaluating for Pediatric Concussion
•16 min
Iron Deficiency in Adults: Advances in Diagnosis and Treatment
•17 min
From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
•15 min
Resistant Hypertension: Diagnosis and Management
•18 min
Update on Peanut Allergy
•19 min
Obesity-Related Cancer
•21 min
Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
•20 min
Does This Patient Have Volume Overload? The Rational Clinical Examination
•19 min
Type 1 Diabetes: Diagnosis and Management
•17 min
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
•33 min

JAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.